Last reviewed · How we verify

Buprenorphine Pill

Duke University · FDA-approved active Small molecule Quality 5/100

Buprenorphine Pill is a Small molecule drug developed by Duke University. It is currently FDA-approved.

At a glance

Generic nameBuprenorphine Pill
SponsorDuke University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Buprenorphine Pill

What is Buprenorphine Pill?

Buprenorphine Pill is a Small molecule drug developed by Duke University.

Who makes Buprenorphine Pill?

Buprenorphine Pill is developed and marketed by Duke University (see full Duke University pipeline at /company/duke-university).

What development phase is Buprenorphine Pill in?

Buprenorphine Pill is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing